Approved Pharma Gate logoPHARMA GATEGLOBAL HEALTHCARE TRADEJoin the networkJoin
Global Healthcare Intelligence/Markets/Regulatory Navigator/Global
← Egypt intelligence
SAFETY ALERTLast verified 2026-10-07

Vancomycin — EDA safety alert

Country
Egypt
Official organization
Egyptian Drug Authority (EDA)
Category
safety watch
Product / sector
Pharmaceuticals
Publication / issue date
2026-04
Document version
Not specified
Official source
vancomycin – risk of hemolytic anemia and Hepatobiliary disorders

OFFICIAL SOURCE FACTS / REQUIREMENT FRAMEWORK

What you need to know

  • The EDA alert addresses haemolytic anaemia, hepatobiliary information and Kounis syndrome in labelling updates.

This summary is not a complete regulatory checklist. Applicability, conditions and exclusions remain governed by the original official document.

Who is affected

  • Marketing Authorization Holders
  • Pharmacovigilance teams
  • Regulatory Affairs
  • Healthcare professionals

PHARMA GATE INTERPRETATION — NOT AN OFFICIAL REQUIREMENT

Pharma Gate Intelligence

Review the complete EDA communication within professional safety and regulatory workflows. This brief provides no individual treatment recommendation.

Business impact

Relevant teams should review the alert for their product-information and safety-monitoring responsibilities.

RECOMMENDED ACTION — NOT A REGULATORY DETERMINATION

What to check

  • Substance and product relevance
  • Full official safety communication
  • Applicable labelling and safety-review responsibilities

Recommended next step

Route the official alert to qualified pharmacovigilance and regulatory reviewers.

  1. Safety alert
  2. Affected product assessment
  3. Official communication
  4. Professional review
Relevant Pharma Gate solutions
  • Regulatory & Product Registration
  • Consulting & Advisory

NEXT STEP

Need help navigating this requirement?

Regulatory StrategyDossier SupportMarket Entry AdvisoryRegulatory Service ProvidersConsulting & AdvisoryTrade & LogisticsLegal & Professional Services

Pharma Gate is not a regulatory authority. Professional providers are independent organizations subject to platform review.

VERIFIED SOURCE GOVERNANCE

Official facts are attributed to issuing authorities. Pharma Gate analysis and recommended actions are clearly separated.

How we verify intelligence

Official facts are attributed to the issuing organization. Pharma Gate interpretation and recommended actions are separate editorial layers, not legal requirements or regulatory approval. Sources are prioritized: national regulators, WHO and recognized intergovernmental bodies, official procurement organizations, then other official governmental or institutional sources.

Publication records retain source title, version, issue date, verification date, country, sector and status. Draft / Public Consultation is distinct from Current. Superseded and Archived records do not represent current requirements. A verification date records the review performed; it is not an assurance of continuous monitoring. Always check the latest official source before acting.